Package 62372-551-51

{"route": ["ORAL"], "spl_id": "0c441a11-2c3b-c0ef-e063-6294a90abc86", "openfda": {"nui": ["N0000010282"], "upc": ["0072799050276"], "unii": ["H0G9379FGK", "92RU3N3Y1O", "NBZ3QY004S"], "rxcui": ["2556794"], "spl_set_id": ["aa694e0d-7891-4870-8106-dd57f1e29fb4"], "pharm_class_pe": ["Skin Barrier Activity [PE]"], "manufacturer_name": ["Infirst Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 TABLET, CHEWABLE in 1 BOTTLE (62372-551-51)", "package_ndc": "62372-551-51", "marketing_start_date": "20210816"}], "brand_name": "Mylanta One Antacid/Anti-Gas", "product_id": "62372-551_0c441a11-2c3b-c0ef-e063-6294a90abc86", "dosage_form": "TABLET, CHEWABLE", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Skin Barrier Activity [PE]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "62372-551", "generic_name": "Calcium carbonate, Magnesium hydroxide, Dimethicone", "labeler_name": "Infirst Healthcare Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Mylanta One Antacid/Anti-Gas", "active_ingredients": [{"name": "CALCIUM CARBONATE", "strength": "1000 mg/1"}, {"name": "DIMETHICONE", "strength": "80 mg/1"}, {"name": "MAGNESIUM HYDROXIDE", "strength": "270 mg/1"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20210504", "listing_expiration_date": "20261231"}